Free Trial

TELA Bio (TELA) Competitors

TELA Bio logo
$1.08 -0.09 (-7.69%)
Closing price 04:00 PM Eastern
Extended Trading
$1.10 +0.02 (+1.85%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TELA vs. ELMD, PROF, LAKE, INGN, DRTS, AVR, BWAY, SKIN, OBIO, and TLSI

Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Electromed (ELMD), Profound Medical (PROF), Lakeland Industries (LAKE), Inogen (INGN), Alpha Tau Medical (DRTS), Anteris Technologies Global (AVR), BrainsWay (BWAY), Beauty Health (SKIN), Orchestra BioMed (OBIO), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

TELA Bio vs.

TELA Bio (NASDAQ:TELA) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership.

Electromed has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$69.30M0.66-$46.66M-$1.39-0.84
Electromed$59.63M3.38$5.15M$0.7531.44

TELA Bio presently has a consensus price target of $7.25, suggesting a potential upside of 519.66%. Electromed has a consensus price target of $38.00, suggesting a potential upside of 61.15%. Given TELA Bio's higher probable upside, research analysts plainly believe TELA Bio is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Electromed has a net margin of 11.34% compared to TELA Bio's net margin of -60.49%. Electromed's return on equity of 15.71% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-60.49% -556.18% -63.13%
Electromed 11.34%15.71%13.37%

TELA Bio received 38 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 74.07% of users gave TELA Bio an outperform vote.

CompanyUnderperformOutperform
TELA BioOutperform Votes
60
74.07%
Underperform Votes
21
25.93%
ElectromedOutperform Votes
22
91.67%
Underperform Votes
2
8.33%

In the previous week, TELA Bio had 2 more articles in the media than Electromed. MarketBeat recorded 3 mentions for TELA Bio and 1 mentions for Electromed. Electromed's average media sentiment score of 0.72 beat TELA Bio's score of 0.05 indicating that Electromed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TELA Bio
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Electromed
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TELA Bio has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500.

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 6.0% of TELA Bio shares are held by insiders. Comparatively, 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Electromed beats TELA Bio on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TELA vs. The Competition

MetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$46.08M$4.28B$5.53B$7.50B
Dividend YieldN/A37.84%4.86%4.05%
P/E Ratio-0.6928.6923.2318.08
Price / Sales0.6645.73362.7586.83
Price / CashN/A51.0838.1634.64
Price / Book1.525.906.493.99
Net Income-$46.66M$67.64M$3.21B$247.18M
7 Day Performance-5.26%-4.92%-4.90%-4.25%
1 Month Performance-50.00%-4.68%-0.07%-6.87%
1 Year Performance-77.80%9.68%6.45%-3.73%

TELA Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TELA
TELA Bio
2.3585 of 5 stars
$1.08
-7.7%
$7.25
+571.3%
-77.9%$42.54M$69.30M-0.64120High Trading Volume
ELMD
Electromed
0.9223 of 5 stars
$24.45
-1.1%
$38.00
+55.4%
+52.8%$209.22M$59.63M32.60160Gap Down
PROF
Profound Medical
2.0151 of 5 stars
$6.81
flat
$14.25
+109.3%
-36.1%$204.57M$10.68M-5.08150
LAKE
Lakeland Industries
4.5898 of 5 stars
$21.09
+12.4%
$28.33
+34.3%
+0.4%$200.33M$151.82M-234.331,800Upcoming Earnings
Gap Down
High Trading Volume
INGN
Inogen
2.3174 of 5 stars
$7.37
+0.3%
$7.00
-5.0%
+1.6%$195.53M$335.71M-3.281,030
DRTS
Alpha Tau Medical
1.9662 of 5 stars
$2.70
+3.4%
$8.00
+196.3%
-14.5%$188.80MN/A-6.2880
AVR
Anteris Technologies Global
N/A$5.12
-1.2%
$16.50
+222.3%
N/A$184.44M$2.71M0.00138Gap Down
High Trading Volume
BWAY
BrainsWay
2.9149 of 5 stars
$9.77
-1.4%
$13.17
+34.8%
+61.6%$183.94M$41.02M97.71120Gap Down
SKIN
Beauty Health
1.6507 of 5 stars
$1.41
+7.6%
$2.50
+77.3%
-66.1%$175.01M$334.29M-3.361,030Positive News
OBIO
Orchestra BioMed
1.51 of 5 stars
$4.57
+1.3%
$15.40
+237.0%
-36.5%$173.72M$2.65M-2.844Earnings Report
Analyst Forecast
News Coverage
Gap Down
TLSI
TriSalus Life Sciences
3.3176 of 5 stars
$5.67
+0.5%
$11.56
+103.9%
-46.6%$172.90M$26.89M-2.28106High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners